Safety Study of GRNOPC1 in Spinal Cord Injury

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Spinal Cord Injury
Interventions
BIOLOGICAL

GRNOPC1

One injection of 2 million GRNOPC1 cells.

Trial Locations (7)

30309

Shepherd Center, Atlanta

53226

The Medical College of Wisconsin, Milwaukee

60611

Northwestern University, Chicago

Unknown

University of Alabama at Birmingham, Birmingham

Stanford University/Santa Clara Valley Medical Center, Palo Alto/San Jose

University of Maryland Medical Center/Kernan Orthopaedics and Rehabilitation Hospital, Baltimore

Thomas Jefferson University Hospital, Philadelphia

All Listed Sponsors
lead

Lineage Cell Therapeutics, Inc.

INDUSTRY

NCT01217008 - Safety Study of GRNOPC1 in Spinal Cord Injury | Biotech Hunter | Biotech Hunter